Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.68
-0.32 (-4.57%)
At close: Mar 13, 2026, 4:00 PM EDT
6.82
+0.14 (2.10%)
After-hours: Mar 13, 2026, 7:26 PM EDT
ARCT Revenue
In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%. Arcturus Therapeutics Holdings had revenue of $7.20M in the quarter ending December 31, 2025, a decrease of -68.39%.
Revenue (ttm)
$82.03M
Revenue Growth
-46.14%
P/S Ratio
2.31
Revenue / Employee
$739,018
Employees
111
Market Cap
189.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 82.03M | -70.28M | -46.14% |
| Dec 31, 2024 | 152.31M | -14.49M | -8.69% |
| Dec 31, 2023 | 166.80M | -39.20M | -19.03% |
| Dec 31, 2022 | 206.00M | 193.64M | 1,566.79% |
| Dec 31, 2021 | 12.36M | 2.82M | 29.56% |
| Dec 31, 2020 | 9.54M | -11.25M | -54.12% |
| Dec 31, 2019 | 20.79M | 5.04M | 31.97% |
| Dec 31, 2018 | 15.75M | 2.76M | 21.20% |
| Dec 31, 2017 | 13.00M | -7.38M | -36.23% |
| Dec 31, 2016 | 20.38M | 14.24M | 232.06% |
| Dec 31, 2015 | 6.14M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 149.50M |
| Compugen | 72.76M |
| MediWound | 16.96M |
| Whitehawk Therapeutics | 7.15M |
| Cartesian Therapeutics | 2.80M |
ARCT News
- 9 days ago - Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
- 11 days ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress - Business Wire
- 25 days ago - Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 - Business Wire
- 4 weeks ago - Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure - Seeking Alpha
- 2 months ago - Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Business Wire